In Key Hearing, Federal Judge Expresses Doubt About Court’s Ability To Take Action on Contract Pharmacy Matter

Tuesday's hearing in a lawsuit involving drug manufacturers denials of 340B pricing on contract pharmacy drugs was held in the Ronald V. Dellums Federal Building in Oakland, Calif.

A federal district judge in Oakland, Calif., on Tuesday expressed doubt that she had jurisdiction to require the U.S. Health and Human Services Department (HHS) to make drug manufacturers repay 340B hospitals for drug discounts that the companies have declined

Read More »

House Set To Act on Bill that Could Result in Higher Medicaid Rebates and 340B Discounts

The U.S. House Energy and Commerce Committee is scheduled to mark up COVID-19 relief legislation today with language that could cause pharmaceutical manufacturers to owe states Medicaid drug rebates worth more than a drug’s average manufacturer price (AMP).

The language

Read More »

Hospitals Ask U.S. Supreme Court to End “Crushing” Medicare Payments Cuts for 340B Drugs

Three national hospital groups and three hospitals yesterday asked the U.S. Supreme Court to overturn a federal appeals court’s 2-1 July 2020 decision that the nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital outpatient

Read More »

AHA Asks CMS to Rein In UHC’s Specialty Pharmacy Policies

The American Hospital Association says UnitedHealthcare's Specialty pharmacy coverage policies undermine the 340B program's intent. | Shutterstock

The American Hospital Association (AHA) last week told the U.S. Centers for Medicare & Medicaid Services (CMS) that insurance company UnitedHealthcare’s (UHC) specialty pharmacy coverage policies “undermine the intent of the 340B program” and should be disallowed.

In a Feb.

Read More »

Biden Administration Position in Supreme Court ACA Case Has 340B Implications

340B hospitals’ Medicare Part B payment challenge is not the only Supreme Court case next term that will impact the 340B program.

The Biden administration late yesterday told the U.S. Supreme Court that, due to the change in the presidency, the federal government has changed its main position in the lawsuit over the Affordable Care Act’s (ACA) constitutionality. The government now says

Read More »

Drug Manufacturers GSK and Esperion Offering Refunds for 340B Overcharges

Glaxo Smith Kline has notified 340B covered entities about the availability of refunds for overcharges early in 2019. | Shutterstock

Drug manufacturer Glaxo Smith Kline (GSK) yesterday notified 340B covered entities on the U.S. Health Resources and Services Administration (HRSA) website that it is offering refunds for overcharges on about two dozen NDCs during the first quarter of 2019.

In

Read More »

Health Centers to Begin Receiving COVID-19 Vaccines Directly

The National Association of Community Health Centers said its members have already begun vaccinating priority populations against the SARS-Cov-2 virus that causes COVID-19. | Shutterstock

As soon as Monday, some federally qualified health centers (FQHCs) will be able to start ordering COVID-19 vaccines for administration to patients, under a “community health centers vaccination program” announced Tuesday by the Biden administration.

The administration said in

Read More »

Burr Named Ranking Republican On Committee with 340B Oversight

U.S. Sen. Richard Burr (R-N.C.) succeeds retired senator Lamar Alexander as the highest-ranking Republican on the Senate HELP Committee.

As expected, U.S. Sen. Richard Burr (R-N.C.) on Tuesday was formally named the highest-ranking Republican member of the Senate Health, Education, Labor, and Pensions (HELP) committee, the Senate committee with jurisdiction over the 340B program.

“As Ranking Member of the

Read More »

Court Hearing Today on Hospitals’ 340B Contract Pharmacy Suit Against HHS

A group of Texas hospitals urged a federal court to grant their request for a summary judgement—or at minimum preliminary relief—in a case challenging an HHS rule.

A federal district judge in Oakland, Calif., is scheduled to hold a hearing this afternoon on the U.S. Health and Human Services (HHS) Department’s motion to dismiss a lawsuit against it by 340B hospitals over HHS’s enforcement of its 340B

Read More »

Welch and McKinley Will Try Again to Get Rural and Cancer Hospitals 340B Pricing on Orphan Drugs

U.S. Reps. Peter Welch (D-Vt.), left, and David McKinley (R-W.Va.) have reintroduced their bill to give 340B rural and free-standing cancer hospitals access to 340B pricing on orphan drugs. | Source: C-SPAN

U.S. Reps. Peter Welch (D-Vt.) and David McKinley (R-W.Va.) have reintroduced bipartisan legislation in the U.S. House to give 340B rural and free-standing cancer hospitals access to 340B pricing on orphan drugs—which according to a 2019 study are 25

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live